ProCE Banner Activity

CME

Webcast: Targeted Therapies for Migraine Prevention in the Challenging Migraineur: Focus on CGRP Blockade

Multimedia
In this dynamic CME-certified video from a live symposium, expert faculty discuss the clinical application of CGRP-targeting agents in migraine prophylaxis.

Physicians: Maximum of 1.00 AMA PRA Category 1 Credit

Released: March 10, 2020

Expiration: March 09, 2021

No longer available for credit.

Share

Faculty

Wade Cooper

Wade Cooper, DO

Director, Headache and Neuropathic Pain
Clinical Associate Professor, Neurology and Anesthesiology
University of Michigan
Ann Arbor, Michigan

Merle Diamond

Merle Diamond, MD

Clinical Assistant Professor
Department of Medicine
Rosalind Franklin University
President
Managing Director

Diamond Headache Clinic
AMITA Health St Joseph Hospital
Chicago, Illinois

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Lundbeck

Target Audience

This program is intended for neurologists, headache specialists, primary care physicians, nurses, and other healthcare providers who treat migraine.

Learning Objectives

Upon completion of this activity, participants should be able to:
  • Identify the challenges and unmet needs for safe and effective reduction of migraine burden in patients with frequent episodic or chronic migraine who cannot tolerate or respond poorly to conventional therapies
  • Describe recent investigations into the role of CGRP in the migraine cascade and the rationale for utilizing CGRP blockade for migraine prophylaxis
  • Compare and contrast available and emerging CGRP blockers with respect to administration features, dosing intervals, and pivotal clinical trial results
  • Consider patients’ expectations, preferences, and unmet needs when selecting a CGRP blocker product for migraine prophylaxis

Disclosure

Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any relevant conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME/CE activity:

Faculty Disclosure

Primary Author

Wade Cooper, DO

Director, Headache and Neuropathic Pain
Clinical Associate Professor, Neurology and Anesthesiology
University of Michigan
Ann Arbor, Michigan

Wade Cooper, DO, has disclosed that he has received consulting fees from Alder, Allergan, Amgen, Lilly, and Teva and fees for non-CME/CE services from Amgen and Lilly.

Merle Diamond, MD

Clinical Assistant Professor
Department of Medicine
Rosalind Franklin University
President
Managing Director

Diamond Headache Clinic
AMITA Health St Joseph Hospital
Chicago, Illinois

Merle Diamond, MD, has disclosed that she has received consulting fees from Amgen, Lilly, Lundbeck, Promius, Supernus, Teva, and Upsher-Smith Laboratories and fees for non-CME/CE services from Amgen, Assertio, Lilly, Lundbeck, Supernus, and Teva.

Staff Disclosure

Staff

Megan Cartwright, PhD

Senior Clinical Editor

Megan Cartwright, PhD, has no relevant conflicts of interest to report.

Anne Roc, PhD

Director, Scientific Services

Anne Roc, PhD, has no relevant conflicts of interest to report.

Zachary Schwartz, MSc, ELS

Scientific Director

Zachary Schwartz, MSc, ELS, has no relevant conflicts of interest to report.

Carolyn Skowronski, PharmD

Associate Director, Scientific Services

Carolyn Skowronski, PharmD, has no relevant conflicts of interest to report.

Instructions for Credit

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

Credit Designation

CCO designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Additional Information

Participation in this self-study activity should be completed in approximately 1 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from March 10, 2020, through March 09, 2021:

1. Register online at http://www.clinicaloptions.com.
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 65% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME/CE activities completed can be found on the "CME/CE Manager" page. There are no costs/fees for this activity.

Program Medium

This program has been made available online.


Goal


The goal of this activity is to improve participants’ knowledge of and competence in applying current and emerging CGRP-based treatment strategies in migraine prevention and treatment.